Co-founder and CEO Anthony Tennyson spoke to Psychedelic Health about Awakn’s mission to transform mental health and addiction care through psychedelics.
A new report from the Conservative Drug Policy Reform Group (CDPRG) has shown the majority of MPs in the UK support drug policy reform, and highlights...
The new UK drug strategy is aiming to reduce drug-related crime through the largest ever increase in funding.
Awakn has signed a Memorandum of Understanding (MOU) with the Devon Partnership NHS Trust and the University of Exeter to increase access to psychedelic-assisted therapy for...
The first ketamine clinic in the UK has received approval from the Care Quality Commission (CQC) to begin treatments.
A new partnership between a Danish and a British startup will lead the way for advancing patient access to medical psychedelics in Europe.
